Ind-Swift Limited (INDSWFTLTD) - Total Liabilities
Based on the latest financial reports, Ind-Swift Limited (INDSWFTLTD) has total liabilities worth Rs11.30 Billion INR (≈ $122.24 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ind-Swift Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Ind-Swift Limited's total liabilities have evolved over time, based on quarterly financial data. See Ind-Swift Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Ind-Swift Limited Competitors by Total Liabilities
The table below lists competitors of Ind-Swift Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Total Telcom Inc
V:TTZ
|
Canada | CA$573.41K |
|
Battery Age Minerals Ltd
AU:BM8
|
Australia | AU$2.63 Million |
|
Intelicare Holdings Ltd
AU:ICR
|
Australia | AU$1.86 Million |
|
Sidomulyo Selaras Tbk
JK:SDMU
|
Indonesia | Rp116.09 Billion |
|
Annexin Pharmaceuticals AB
ST:ANNX
|
Sweden | Skr5.56 Million |
|
Bekasi Asri Pemula Tbk
JK:BAPA
|
Indonesia | Rp17.32 Billion |
|
Buru Energy Ltd
AU:BRU
|
Australia | AU$14.49 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Ind-Swift Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INDSWFTLTD market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.25 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ind-Swift Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ind-Swift Limited (2006–2025)
The table below shows the annual total liabilities of Ind-Swift Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs11.30 Billion ≈ $122.24 Million |
-15.98% |
| 2024-03-31 | Rs13.45 Billion ≈ $145.49 Million |
-0.64% |
| 2023-03-31 | Rs13.54 Billion ≈ $146.42 Million |
+0.14% |
| 2022-03-31 | Rs13.52 Billion ≈ $146.22 Million |
-1.07% |
| 2021-03-31 | Rs13.67 Billion ≈ $147.81 Million |
+3.95% |
| 2020-03-31 | Rs13.15 Billion ≈ $142.19 Million |
+3.14% |
| 2019-03-31 | Rs12.75 Billion ≈ $137.85 Million |
-0.25% |
| 2018-03-31 | Rs12.78 Billion ≈ $138.20 Million |
-0.17% |
| 2017-03-31 | Rs12.80 Billion ≈ $138.43 Million |
-1.55% |
| 2016-03-31 | Rs13.00 Billion ≈ $140.62 Million |
+2.60% |
| 2015-03-31 | Rs12.67 Billion ≈ $137.06 Million |
-1.10% |
| 2014-03-31 | Rs12.81 Billion ≈ $138.58 Million |
+7.68% |
| 2013-03-31 | Rs11.90 Billion ≈ $128.70 Million |
-4.57% |
| 2012-03-31 | Rs12.47 Billion ≈ $134.87 Million |
+37.44% |
| 2011-03-31 | Rs9.07 Billion ≈ $98.13 Million |
+21.59% |
| 2010-03-31 | Rs7.46 Billion ≈ $80.71 Million |
+30.40% |
| 2009-03-31 | Rs5.72 Billion ≈ $61.89 Million |
+6.16% |
| 2008-03-31 | Rs5.39 Billion ≈ $58.30 Million |
+31.73% |
| 2007-03-31 | Rs4.09 Billion ≈ $44.26 Million |
+61.12% |
| 2006-03-31 | Rs2.54 Billion ≈ $27.47 Million |
-- |
About Ind-Swift Limited
Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. The company offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin… Read more